Amy Paul

Amy Paul

Auto-generated profile, based on publicly available information

Amy Paul

Department of Pathology and Molecular Medicine, McMaster University

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Transplantation Proceedings
Verified
Journal Article
Closed access
FSFuat H. Saner
Fuat H. Saner
GSG.C. Sotiropoulos
G.C. Sotiropoulos
ARA. Radtke
A. Radtke
IFI. Fouzas
I. Fouzas
EME.P. Molmenti
E.P. Molmenti
APA. Paul
A. Paul

1 January 2023 in Canadian Journal of Kidney Health and Disease
Verified
Journal Article
Open access
APAmy Paul
Amy Paul
ALAllison Lawlor
Allison Lawlor
KCKristina Cunanan
Kristina Cunanan
PGPukhraj S. Gaheer
Pukhraj S. Gaheer
AKAditya Kalra
Aditya Kalra
DBDarren Bridgewater
Darren Bridgewater
Purpose of review: Multiple large-scale genome-wide association meta-analyses studies have reliably identified an association between genetic variants within the SHROOM3 gene and chronic kidney disease. This association extends to alterations in known markers of kidney disease including baseline estimated glomerular filtration rate, urinary albumin-to-creatinine ratio, and blood urea nitrogen. Yet, an understanding of the molecular mechanisms behind the association of SHROOM3 and kidney disease remains poorly communicated. We conducted a narrative review to summarize the current state of literature regarding the genetic and molecular relationships between SHROOM3 and kidney development and disease. Sources of information: PubMed, PubMed Central, SCOPUS, and Web of Science databases, as well as review of references from relevant studies and independent Google Scholar searches to fill gaps in knowledge. Methods: A comprehensive narrative review was conducted to explore the molecular mechanisms underlying SHROOM3 and kidney development, function, and disease. Key findings: SHROOM3 is a unique protein, as it is the only member of the SHROOM group of proteins that regulates actin dynamics through apical constriction and apicobasal cell elongation. It holds a dichotomous role in the kidney, as subtle alterations in SHROOM3 expression and function can be both pathological and protective toward kidney disease. Genome-wide association studies have identified genetic variants near the transcription start site of the SHROOM3 gene associated with chronic kidney disease. SHROOM3 also appears to protect the glomerular structure and function in conditions such as focal segmental glomerulosclerosis. However, little is known about the exact mechanisms by which this protection occurs, which is why SHROOM3 binding partners remain an opportunity for further investigation. Limitations: Our search was limited to English articles. No structured assessment of study quality was performed, and selection bias of included articles may have occurred. As we discuss future directions and opportunities, this narrative review reflects the academic views of the authors.

1 January 2002
Verified
Book Chapter
Closed access
PDF file
APA. Paul
A. Paul
MFM. Frackowiak
M. Frackowiak
EEE. Eypasch
E. Eypasch
SFSarah O. Fischer
Sarah O. Fischer
MNM. Nagelschmidt
M. Nagelschmidt
HTH. Troidl
H. Troidl

11 February 2024 in medRxiv
Verified
Preprint
Open access
PDF file
PGPukhraj S. Gaheer
Pukhraj S. Gaheer
NUNikhil Uppal
Nikhil Uppal
APAmy Paul
Amy Paul
PMPedrum Mohammadi-Shemirani
Pedrum Mohammadi-Shemirani
NPNicolas Perrot
Nicolas Perrot
Matthew B. LanktreeMatthew B. Lanktree
Matthew B. Lanktree
Shroom Family Member 3 ( SHROOM3) encodes an actin-binding protein that impacts kidney development. Genome-wide association studies (GWAS) identified CKD-associated common variants around SHROOM3 and Shroom3 knock-out mice develop glomerular abnormalities. We sought to evaluate the impact of genetically predicted SHROOM3 expression on kidney traits and the circulating proteome, and validate findings in a mouse model. Genetic instruments for SHROOM3 expression in distinct kidney compartments (glomerular n=240, tubulointerstitial n=311) were constructed using single cell sequencing data from NephQTL2. Using two-sample Mendelian randomization, we evaluated the effects of glomerular and tubulointerstitial SHROOM3 expression on kidney traits and the concentration of 1,463 plasma proteins in the UK Biobank and CKDGen Consortium. Genetically predicted tubulointerstitial SHROOM3 expression colocalized with the genetic signals for eGFR and albuminuria. A 34% reduction in genetically predicted tubulointerstitial SHROOM3 expression was associated with a 0.3% increase in cross-sectional eGFR ( P = 6.8×10 -4 ), a 1.5% increase in albuminuria ( P = 0.01), and a 2.2% reduction in plasma COL18A1 concentration ( P = 1.2×10 -5 ). In contrast, genetically predicted glomerular SHROOM3 expression showed neither colocalization nor significant Mendelian randomization results. Using immunofluorescence, heterozygous Shroom3 knockout mice had a concordant reduction of Col18a1 in their kidneys, primarily around the tubules. Thus, reduced tubulointerstitial SHROOM3 expression, but not glomerular, is associated with increased cross-sectional eGFR, increased uACR, and reduced plasma COL18A1 and Shroom3 knockout leads to reduced kidney Col18a1, agnostically linking SHROOM3 and COL18A1 in CKD pathogenesis. Lay Summary: The SHROOM3 gene is consistently linked to kidney disease, but we have yet to fully understand why. We looked at how genetic changes affecting SHROOM3 impact different regions of the kidney. We found that less SHROOM3 in kidney tubules led to increased kidney filtration, but also increased leakage of protein into the urine. After looking at over 1000 proteins, we identified a new link between SHROOM3 and a collagen protein called COL18A1. We then confirmed the link between SHROOM3 and COL18A1 by imaging the kidneys of mice designed to have less SHROOM3. Our results suggest an interaction of SHROOM3 and COL18A1 leads to increased pressure on the kidney filtration system.

2 July 2013 in DMW - Deutsche Medizinische Wochenschrift
Verified
Journal Article
Closed access
KHKerstin Herzer
Kerstin Herzer
APA. Paul
A. Paul
GGG. Gerken
G. Gerken